Education
About Us
Working with TipRanks
Follow Us
Akoya Biosciences (AKYA)
NASDAQ:AKYA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 81.67M | $ 96.63M | $ 74.86M | $ 54.92M | $ 42.44M |
| Gross Profit | $ 47.88M | $ 56.30M | $ 43.39M | $ 34.22M | $ 25.91M |
| Operating Income | $ -46.73M | $ -57.67M | $ -66.21M | $ -37.23M | $ -11.49M |
| EBITDA | $ -46.73M | $ -45.63M | $ -58.81M | $ -35.17M | $ -10.13M |
| Net Income | $ -55.37M | $ -63.32M | $ -70.64M | $ -42.94M | $ -16.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 35.04M | $ 83.13M | $ 81.22M | $ 113.08M | $ 17.01M |
| Total Assets | $ 125.00M | $ 180.37M | $ 176.03M | $ 190.91M | $ 77.66M |
| Total Debt | $ 7.96M | $ 85.71M | $ 75.78M | $ 32.47M | $ 34.99M |
| Net Debt | $ -3.81M | $ 2.58M | $ 1.55M | $ -80.61M | $ 17.99M |
| Total Liabilities | $ 117.41M | $ 126.60M | $ 117.45M | $ 69.56M | $ 59.09M |
| Stockholders' Equity | $ 7.59M | $ 53.77M | $ 58.58M | $ 121.35M | $ 18.57M |
| Cash Flow | |||||
| Free Cash Flow | $ -46.56M | $ -54.55M | $ -60.86M | $ -41.16M | $ -10.14M |
| Operating Cash Flow | $ -44.10M | $ -50.90M | $ -53.50M | $ -36.07M | $ -6.84M |
| Investing Cash Flow | $ -24.05M | $ 3.35M | $ -14.08M | $ -5.09M | $ 6.73M |
| Financing Cash Flow | $ -3.21M | $ 56.84M | $ 28.73M | $ 137.03M | $ 5.49M |